China Immunotech (华夏英泰(北京)生物技术有限公司) is a Beijing‑based biotechnology company founded in March 2018. It focuses on innovative gene‑edited T‑cell immunotherapy products, including CAR‑T and TCR‑T platforms (STAR‑T and enTCR‑T), targeting solid tumours, haematological malignancies and viral infections. The firm aims to translate cutting‑edge research from Tsinghua University into commercial therapies for unmet clinical needs.
Chinaimmunotech is profiled on the APIs.io network. Tagged areas include Company.
Regulatory Posture applies to this provider. Its tags matched the
Horizontal (data, software, accessibility, platform) regime, so
Regulatory Posture carries 15 points of the composite.
If this regime is wrong for your business, say so on your
provider repo — the
applicability map is public and we will correct it.
Create-or-Update Ergonomics could not be measured. We hold no machine-readable contract for
this provider to read, so there is nothing to measure a write surface against. Excluded rather than scored zero:
never-measured and measured-empty are different facts. Publishing an OpenAPI is what makes this facet — and
several others — scorable at all.
The six quality facets above are damped to 85 points between them,
because the conditional facet above carries the other
15. That is why each facet's contribution is shown against a damped
maximum: raising a quality facet moves the composite by 85% of its nominal
weight, not 100%. The full arithmetic is at apis.io/rating/.
aid: chinaimmunotech
name: Chinaimmunotech
description: China Immunotech (华夏英泰(北京)生物技术有限公司) is a Beijing‑based biotechnology company founded in March 2018. It focuses
on innovative gene‑edited T‑cell immunotherapy products, including CAR‑T and TCR‑T platforms (STAR‑T and enTCR‑T), targeting
solid tumours, haematological malignancies and viral infections. The firm aims to translate cutting‑edge research from Tsinghua
University into commercial therapies for unmet clinical needs.
url: https://raw.githubusercontent.com/api-evangelist/chinaimmunotech/refs/heads/main/apis.yml
x-type: company
x-source: harvest:secondary-market
x-tier: profiled
x-tier-reason: enrichment pass 2026-10-08 (modular-v1; was harvest)
specificationVersion: '0.20'
created: '2026-10-08'
modified: '2026-10-08'
tags:
- Company
maintainers:
- FN: Kin Lane
email: kin@apievangelist.com
- FN: APIs.json
email: info@apis.io
common:
- type: Hosts
url: hosts/chinaimmunotech-hosts.yml
- type: DomainSecurity
url: security/chinaimmunotech-domain-security.yml
- type: Website
url: https://www.bristarimmunotech.com
apis: []
x-coverage:
state: unreadable
reason: js-rendered-docs
detail: The homepage returns a JavaScript shell with no machine‑readable API documentation.
evidence:
- url: https://www.bristarimmunotech.com
status: 200
checked: '2026-10-08'
x-enrichment:
date: '2026-10-08'
status: enriched
artifacts_added: 4
pass: modular-v1
engine: identity=local,contract=local,surfaces=local,docs=local,regulatory=local
Discovery needs no key. Ratings and market analysis are Pro.
Get an API key
Free tier, no form to fill in. Signing in shares your email address with us — we
store it to create your key and to recognise you if you sign in with another
provider. See our Privacy Policy and
Terms.
Kin Score
How this is scored →